MFIM
CEMI

Mesirow Financial Investment Management’s Chembio diagnostics, Inc. CEMI Stock Holding History

Mesirow Financial Investment Management’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-38,382
Closed -$235K – 73
2019
Q3 		$235K Sell
38,382
-396
-1% -$2.36K 0.99% 56
2019
Q2 		$219K Buy
+38,778
New +$262K 0.8% 52

Other funds holding CEMI

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Mesirow Financial Investment Management's CEMI Position: Q4 2019 in Review

Mesirow Financial Investment Management sold out of Chembio diagnostics, Inc. (CEMI) in Q4 2019, closing a stake of 38,382 shares — an estimated $235K sold.

Mesirow Financial Investment Management first reported a position in CEMI in Q2 2019 and held it in 2 quarters. The position peaked at $235K in Q3 2019. 39 funds tracked by Wall St. Rank hold CEMI as of Q4 2019.

  • Mesirow Financial Investment Management reported no remaining Chembio diagnostics, Inc. position as of Q4 2019 after selling out during the quarter.
  • Mesirow Financial Investment Management sold 38,382 Chembio diagnostics, Inc. shares in Q4 2019, an estimated $235K.
  • Mesirow Financial Investment Management first reported a position in Chembio diagnostics, Inc. in Q2 2019 and held it in 2 quarters.
  • Mesirow Financial Investment Management's Chembio diagnostics, Inc. position peaked at $235K in Q3 2019.
  • 39 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q4 2019.

Based on Mesirow Financial Investment Management's 13F filing for Q4 2019, filed 9 Jan 2020.